Tirzepatide 5mg is a once-weekly subcutaneous injection developed by Eli Lilly and Company and marketed under the brand name Mounjaro for type 2 diabetes
While it's essential to recognize that the FDA does not endorse off-label use, the demand for Ozempics weight loss magic couldn't be ignored, leading to practitioners across the country taking the obesity fight into their own handsor prescription pads
At PlexusDx, we offer free assessments to determine eligibility for PlexusDx's prescription weight loss medications, ensuring that you are set up for success from the beginning
The central legal concern may revolve around whether Novo Nordisk, the maker of Ozempic, Wegovy, and Rybelsus, was aware or ought to have been aware of the increased risk of gastroparesis or stomach paralysis associated with these drugs, yet neglected to adequately inform doctors and patients about this danger
With regular use, skin appears brighter, softer, and more luminous